Derma-Smoothe/FS (Body Oil) Interactions
There are 47 drugs known to interact with Derma-Smoothe/FS (Body Oil) (fluocinolone topical), along with 5 disease interactions. Of the total drug interactions, 47 are moderate.
- View all 47 medications that may interact with Derma-Smoothe/FS (Body Oil)
- View Derma-Smoothe/FS (Body Oil) disease interactions (5)
Most frequently checked interactions
View interaction reports for Derma-Smoothe / FS (Body Oil) (fluocinolone topical) and the medicines listed below.
- acetaminophen
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Adhansia XR (methylphenidate)
- Advil Children's (ibuprofen)
- albuterol
- Allegra (fexofenadine)
- alprazolam
- amoxicillin
- Aptensio XR (methylphenidate)
- cetirizine
- cholecalciferol
- clobetasol topical
- clonidine
- cyclobenzaprine
- Cymbalta (duloxetine)
- Diamox (acetazolamide)
- diazepam
- Diuril (chlorothiazide)
- doxycycline
- Emergen-C (multivitamin with minerals)
- enoxaparin
- escitalopram
- Flagyl (metronidazole)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Fosamax (alendronate)
- hydrocortisone
- Triple Antibiotic (bacitracin / neomycin / polymyxin b topical)
Derma-Smoothe/FS (Body Oil) disease interactions
There are 5 disease interactions with Derma-Smoothe / FS (Body Oil) (fluocinolone topical) which include:
More about Derma-Smoothe / FS (Body Oil) (fluocinolone topical)
- Derma-Smoothe/FS (Body Oil) consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy or Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.